Working Group: Member Bios

 

 

Alfred O. Berg, M.D., M.P.H., chair of the EGAPP Working Group, is professor and chair of the Department of Family Medicine at the University Of Washington School of Medicine, Seattle. Dr. Berg received his professional education at Washington University, St. Louis, the University of Missouri, Columbia, and the University of Washington, Seattle. He is board certified in Family Medicine and in General Preventive Medicine and Public Health, and is a member of the Institute of Medicine of the National Academy of Sciences. Dr. Berg's research has focused on clinical epidemiology in primary care settings. He has been active on many expert panels using evidence-based methods to develop clinical guidelines, including chairmanship of the United States Preventive Services Task Force, co-chair of the otitis media panel convened by the Agency for Health Care Policy and Research, chair and moderator of the CDC STD Treatment Guidelines panel, member of the AMA/CDC panel producing Guidelines for Adolescent Preventive Services, and member of the Institute of Medicine's Immunization Safety Review Committee.

Jeff Botkin is a Professor of Pediatrics at the University of Utah, an Adjunct Professor of Internal Medicine in the Division of Medical Ethics and an Adjunct Professor of Human Genetics. He is the Associate Vice President for Research Integrity at the University of Utah with oversight responsibilities for the IRB, conflict of interest, responsible conduct of research, biosafety, and research ethics education. He was an undergraduate at Princeton University and received his MD at the University of Pittsburgh, an MPH at Johns Hopkins University and was a fellow in Law, Ethics and Health at Johns Hopkins in affiliation with the Kennedy Institute of Ethics at Georgetown. He has over 20 years of experience in the clinical care of pediatric patients. His research is focused on the ethical, legal, and social implications of genetic technology with a particular emphasis on research ethics, genetic testing for cancer susceptibility, newborn screening, and prenatal diagnosis. Dr. Botkin is the former Chair of the Committee on Bioethics for the American Academy of Pediatrics and a current member of the DHHS Secretary's Advisory Committee on Human Research Protections. He is a fellow of the Hastings Center.

Dr. Ned Calonge is the Chief Medical Officer of the Colorado Department of Public Health and Environment, and the State Epidemiologist. He is an Associate Professor of Family Medicine and of Preventive Medicine and Biometrics at the University of Colorado Health Sciences Center.

 

At the Department of Public Health and Environment, Dr. Calonge is responsible for supervision of health-related divisions. These include the Disease Control and Environmental Epidemiology Division, which is responsible for disease outbreak investigation and bioterrorism preparedness and response; the Health Facilities and Emergency Medical Services Division, which provides licensing and regulatory oversight for long term care facilities, personal care boarding homes, ambulatory surgical centers, convalescent centers, hospitals and HMOs as well as oversight and certification for Emergency Medical Technicians, the state Trauma System and pre-hospital care; the Preventive Services Division, which provides direct and collaborative community-based disease prevention services as well as addressing community programs for disease prevention and health promotion for vulnerable populations; the Laboratory Services Division, which provides laboratory support for core public health and environmental protection programs including infectious disease and regulatory surveillance and compliance; and the Colorado Health and Environment Information Services Division which collects and maintains vital records, health survey data, and environmental exposure data. Dr. Calonge is a member of the Governor's Expert Emergency Epidemic Response Committee and chairs the state Bioterrorism Advisory and Hospital Preparedness Advisory Committees.

 

Outside of the Department, Dr. Calonge is the President of the Colorado Board of Medical Examiners, which licenses and provides regulatory oversight for physicians and physician assistants. He is currently the Chair of the United States Preventive Services Task Force, a federal panel of experts that sets national recommendations for preventive health care. He teaches epidemiology, biostatistics and research methods at the University of Colorado Health Sciences Center. He serves on the Boards of Directors for the Colorado Academy of Family Practice, the Colorado Foundation for Medical Care, and the Colorado Patient Safety Coalition. At the Colorado Medical Society he chairs the Health Affairs Committee.

 

Previous to his appointment at the Department of Public Health and Environment in January 2002, Dr. Calonge was the Chief of Preventive Medicine and Research for Kaiser Permanente of Colorado, where he was responsible for the development, implementation and evaluation of evidence-based preventive medicine guidelines and prevention programs and provided leadership, management and research consultation for the Kaiser Permanente Clinical Research Unit.

 

Dr. Calonge received his BA in Chemistry from The Colorado College in Colorado Springs, his MD from the University of Colorado in Denver and his MPH from the University of Washington in Seattle; he is board certified in both Family Medicine and Preventive Medicine. Dr. Calonge has published numerous federally funded research articles on various topics in the medical literature. He is the 2004 recipient of both the Public Health Award and the Robert Grams Physician Executive Award given by the American Academy of Family Physicians.

Dr. Campos-Outcalt is the Associate Chair for the University of Arizona College of Medicine, Department of Family and Community Medicine, Phoenix Campus and the Assistant Dean for Outreach and Multicultural Affairs. He is Board certified in both Family Medicine and Preventive Medicine/Public Health.  He is a practitioner and educator of public health and family medicine. He currently serves as a scientific analyst for the American Academy of Family Physicians (AAFP) and as the AAFP liaison to the Advisory Committee on Immunization Practices of the CDC and to the United States Preventive Services Task Force.

Since the mid 1970s, Dr. Haddow's interests have focused on medical screening. Between 1974 and 1977, he and his staff developed the first statewide prenatal screening program for open neural tube defects in the United States and then expanded it in the 1980s and 90s to include Down syndrome. In collaboration with other investigators, he and his staff discovered one of the serum markers now in widespread use as a Down syndrome screening marker (unconjugated estriol). Later in the 1990s, he and his staff, together with another group of collaborators, carried out a population study that documented a relationship between undetected thyroid deficiency in the mother during pregnancy and lower IQ in the offspring. As an extension of these interests, Dr. Haddow established the Scarborough Conferences, aimed at bringing together representative scientists, policy makers, regulators and consumers to examine public health implications of new screening initiatives. These conferences are convened on an as-needed basis, rather than annually. More recently, Dr. Haddow has become involved with developing a process (the ACCE process) to assess screening and diagnostic tests in the field of genetics. This activity has expanded his overall area of topical interests to include hereditary breast cancer, colorectal cancer, hemochromatosis, and other disorders. In general, his efforts are currently directed at finding ways to improve the translation of research into practice.

Dr. Maxine Hayes is the State Health Officer for the Washington State Department of Health. She advises the Governor and the Department of Health Secretary on issues ranging from emergency response to outbreaks to preventing childhood illness. She works closely with the medical community, local health departments, and community groups to give the public the latest scientific information on how to become and stay healthy.

Prior to her appointment as Health Officer, Dr. Hayes was the Assistant Secretary of Community and Family Health. Dr. Hayes is clinical professor of pediatrics at the University of Washington, School of Medicine, and on the MCH faculty of the School of Public Health.

Dr. Hayes was the 1999 Distinguished Alumna of the Year for the State University of New York School of Medicine at Buffalo and the Year 2000 recipient of the Stockton Kimball Award. In 2000 she was presented an honorary Doctorate of Science by former Acting Surgeon General and President of Spelman College, Dr. Audrey Manley. She is the recipient of many awards and honors for her work in maternal and child health, including the American Medical Association's 2002 Dr. Nathan Davis Award and the 2003 Heroes in Health Care Lifetime Achievement Award through the Washington Health Foundation. Dr. Hayes is also a fellow of the American Academy of Pediatrics and was elected to the Institute of Medicine in October 2006.

Dr. Celia Kaye is the Senior Associate Dean for Education of the School of Medicine at the University of Colorado at Denver and Health Sciences Center.  A geneticist and professor of pediatrics at the university, Dr. Kaye joined the faculty in 2005.

Dr. Kaye came to the Health Sciences Center from the University of Texas Health Science Center at San Antonio, where she served as Vice Dean, School of Medicine, from 2001-2005 and Chair, Department of Pediatrics from 1997-2002.  Dr. Kaye was Chief of the Division of Pediatric Genetics and Birth Defects in San Antonio from 1989-1997.  Prior to her service in San Antonio, Dr. Kaye served on the faculty at the University of  Illinois College of Medicine in Chicago.  She was co-medical director of the Perinatal Center and Director of Pediatric Genetics and the Genetics Laboratory at Lutheran General Hospital, Park Ridge, Illinois.

 

Dr. Kaye is a member of the American Pediatric Society, the Society for Pediatric Research, the American College of Medical Genetics, the American Academy of Pediatrics, and numerous other professional organizations in Pediatrics and Genetics.  She currently is a member of the Evidence Based Decision Making Workgroup, Maternal and Child Health Bureau, HRSA; the Evaluation of Genome Applications in Practice and Prevention (EGAPP) Workgroup, Centers for Disease Control, and the Steering Committee, National Newborn Screening and Genetics Resource Center, a cooperative agreement between HRSA and the University of Texas Health Science Center at San Antonio.  She is a member of the Workgroup on Newborn Screening and the Medical Home, convened by the American Academy of Pediatrics; she served as a member of the AAP Committee on Genetics from 1999-2005 and the Uniform Panel Workgroup of the American College of Medical Genetics from 2002-2004.  Dr. Kaye has served as principle investigator of numerous federally funded grants; she is the author of many peer-reviewed publications, abstracts and chapters.  She has served as a grant reviewer for the NIH and HRSA, and is a reviewer for a number of scientific journals.  Dr. Kaye’s research interests include chromosome 18 deletion syndromes, and access to genetic services in newborn screening populations.

Roger D. Klein, MD, JD is Medical Director of Molecular Diagnostics at H. Lee Moffitt Cancer Center and Assistant Professor of Oncologic Sciences at the University of South Florida College of Medicine.  He pursued his undergraduate and medical degrees and an internship in Internal Medicine at Case Western Reserve University in Cleveland, Ohio.

 

He completed residency training in Laboratory Medicine along with fellowships in Medical Microbiology and Molecular Genetics at Yale University School of Medicine in New Haven, Connecticut, followed by a fellowship in Molecular Genetic Pathology at Mayo Clinic in Rochester, Minnesota.  He is board-certified in Clinical Pathology and Molecular Genetic Pathology.  Dr. Klein earned his law degree at Yale Law School, where he was named an Olin Fellow for Law and Public Policy Studies.

 

His academic and clinical interests involve the translation of molecular genetic knowledge into clinical diagnostic tests for the evaluation and management of hematopoietic and solid tumor malignancies and hereditary cancer syndromes.  In addition, Dr. Klein has an active research program on the ethical, legal and social implications of the Human Genome Project, with particular emphases in the areas of intellectual property and in vitro diagnostics and clinical laboratory regulation.  Dr. Klein has served on the College of American Pathologists (CAP) "Biochemical and Molecular Genetics," and "Point-of-Care Testing" Resource Committees, and is currently a member of the CAP "Molecular Oncology" Committee.  He serves as a consultant to the FDA's Clinical and Molecular Genetics Advisory Panel, and is a member of the Editorial Board of the journal Pharmacogenomics.

Dr. Offit is Chief of the Clinical Genetics Service at Memorial Hospital in New York and Vice-Chairman of the Program in Cancer Prevention, Control and Population Research at Memorial Sloan-Kettering Cancer Center.  He is also a Professor of Medicine and Public Health at the Weill College of Medicine of Cornell University.

 

Dr. Offit completed training in clinical oncology and cancer genetics and joined the faculty at Memorial Sloan-Kettering Cancer Center in 1988.  Working in the Chaganti Laboratory, he focused on molecular cytogenetic studies of non-Hodgkin’s lymphoma.  He organized one of the first genetic risk assessment programs at a comprehensive cancer center; this service is now one of the largest programs seeing both adult and pediatric cancer patients and their families affected by hereditary malignancies.  Dr. Offit’s research group discovered the most common mutation associated with hereditary breast and ovarian cancer, present in those of Ashkenazi Jewish ancestry.  His group also published the first prospective study showing efficacy of genetic testing combined with preventive ovarian surgery for women carrying BRCA mutations.  Recently, he has conducted whole genome association studies to elucidate low penetrance cancer predisposition alleles, and is actively engaged in policy discussions relating to the most responsible means to clinically translate these research findings.

 

Dr. Offit attended Princeton University, the Harvard Medical School, and the Harvard School of Public Health. He was one of the initial members of the Working Group on Cancer Genetics of the National Cancer Institute and chaired the Sub-Committee on Cancer Genetics of the American Society of Clinical Oncology.  Dr. Offit is a recipient of a career research award from the American Cancer Society.

Stephen G. Pauker, MD, MACP, FACC, ABMH, is professor of medicine and psychiatry at Tufts University School of Medicine and Tufts Medical Center. He is a member of the Division of Clinical Decision Making, Informatics and Telemedicine, which he founded almost forty years ago. Dr. Pauker recently stepped down from his role as Associate Physician-in-Chief at the Tufts Medical Center from 1995-2008.

 

Board-certified in internal medicine, cardiology and medical hypnosis, Dr. Pauker is a member of the Institute of Medicine of the National Academies of Science, of the Association of American Physicians and of the American Society for Clinical Investigation. He is a past president of the Society for Medical Decision Making, now serving as its historian. He is a Master of the American College of Physicians, a Fellow of the American College of Medical Informatics, the American College of Cardiology, and the American Society for Clinical Hypnosis.

 

Dr. Pauker’s research has been in both clinical decision making and medical informatics. He has authored over 250 scientific papers in health policy, decision making, informatics, cardiology, and the study of how physicians reason.  He has published widely on the applications of quantitative tools and reasoning in clinical medicine. He designed and implemented one of the first computer programs to apply artificial intelligence techniques to medicine and developed some of the basic techniques of clinical decision making and cost-effectiveness analysis. His decision analyses include a model to support prospective parents deciding about prenatal diagnosis and models that have examined the cost-effectiveness of screening.

 

Dr. Pauker has participated in numerous consensus conferences (sponsored by NIH, by the Institute of Medicine, the American College of Physicians, American College of Chest Physicians, and the National Blue Cross Blue Shield Technology Evaluation Committee). He has been an active participant in developing the conferences methodologies and classification schemata for evaluating the quality of clinical evidence and the relation between quality of evidence and the strength of clinical effect.  Dr. Pauker is both a methodologist and an active clinician. 

 

A graduate of Harvard College, Dr. Pauker received his medical degree from Harvard Medical School in 1968. He completed an internship at Boston City Hospital and residency training at Massachusetts General Hospital. He also served a clinical fellowship in cardiology at the New England Medical Center Hospital and a research fellowship in cardiology at Massachusetts General Hospital.

Margaret Piper, PhD, MPH is an Associate Director with the Blue Cross and Blue Shield Association (BCBSA) Technology Evaluation Center (TEC), an Agency for Healthcare Research and Quality-funded Evidence-based Practice Center. She has been with TEC since 1994, joining the staff full-time in 1999. Her experience at TEC has focused on systematic reviews of medical technology, including genetic testing. TEC systematic reviews and reports are publicly available on the TEC web site (www.bcbs.com/tec). Dr. Piper can communicate with BCBSA health care plan medical directors and solicit their needs/concerns and those of the populations they serve.

Prior experience includes over 13 years of managing a variety of clinical diagnostic laboratory departments, designing and evaluating new laboratory diagnostics, consulting with physicians, publishing, and volunteer teaching for professional organizations in laboratory medicine. Following a mid-career MPH in epidemiology, Dr. Piper gained experience in cancer epidemiology at the National Cancer Institute and the Centers for Disease Control and Prevention, with a focus on cancer genetics.

Dr. Carolyn Sue Richards is currently professor of Molecular and Medical Genetics and Scientific Director, Molecular Diagnostic Center at Oregon Health & Science University. Dr. Richards received her Ph.D. from Baylor College of Medicine and is certified by the American Board of Medical Genetics in Clinical Biochemical/Molecular Genetics. She has been a molecular genetic laboratory director for 18 years.

Dr. Richards is a Founding Fellow of the American College of Medical Genetics (ACMG), and is the Chair of the ACMG Laboratory Quality Assurance Committee. She is also a member of the Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) Area Committee on Molecular Methods, and Co-Chair of the CLSI Working Group on Molecular Diagnostic Methods for Genetic Diseases. She is on the Board of Directors of the Wolfson Institute for Preventive Medicine as well as the American Collegte of Medical Genetics (2007-2013) and an Advisory Board member for the Eurogentest Network.

Dr. Richard's research interests are germline mutations in cancer genes and ultra-rare genetic disorders. The focus of her laboratory in recent years has been the development of a sequence-based approach to identify germline mutations in cancer genes and defining the biological and functional significance of sequence variants in the dystrophin gene. New directions include clinical research collaborative projects focusing on mutational analysis of Rett syndrome patients (MeCP2 gene) and Fanconi anemia patients (FANC genes).

Joan Scott is a certified genetic counselor with over 25 years of experience in clinical, laboratory, and genetic policy. Her clinical experience is extensive and varied: she practiced clinically for sixteen years in a variety of academic, outreach, and private practice settings including pediatric, adult, and reproductive clinics and provided education for health care professionals. In addition, while at the University of Colorado Health Science Center, she coordinated the genetic counseling training program for five years and provided clinical supervision for students. Ms. Scott worked in the genetics industry for eight years as General Manager and Director of Genetic Services at a clinical diagnostic lab and as Director of a biorepositoy in a biotech company. For the last four years, she has served as Deputy Director at the Genetics and Public Policy Center at Johns Hopkins University. The Center is an objective source of information, research, and policy analysis to help policymakers in the public and private sector to carefully consider and respond to the challenges and opportunities arising from advances in human genetics.

 

Professionally, Ms. Scott has served on numerous boards and committees including the American Society of Human Genetics and the Board of Directors of the National Society of Genetic Counselors and American Board of Genetic Counseling (ABGC). She has served on regional genetic service networks in both Colorado and California and currently advises the Genetic Alliance BioBank, the Ferre Institute, and the Johns Hopkins/NHGRI Genetic Counseling Training Program.

Dr. Strickland is Professor in the Nell Hodgson Woodruff School of Nursing at Emory University in Atlanta, Georgia. Previously Dr. Strickland was professor in the School of Nursing of the University of Maryland at Baltimore. She has taught at the University of North Carolina at Greensboro and North Carolina Agricultural and Technical State University, Greensboro. She has held nursing positions at Davidson County Health Department and Harlem Hospital Center in New York City.

 

Dr. Strickland earned a doctoral degree in child development and family relations from the University of North Carolina, Greensboro. She took a master's degree in maternal and child health nursing from Boston University, Massachusetts, and received a bachelor's degree in nursing from North Carolina Agricultural and Technical State University, Greensboro. She received Honorary Doctorate of Science degrees from the Ohio Medical College, Toledo, Ohio; and Grand Valley State University, Allendale, Michigan.

 

Dr. Strickland is the founding editor of the Journal of Nursing Measurement. She has also served on the editorial boards or review panels of Advances in Nursing Science, Research in Nursing and Health, Nursing Outlook, Journal of Professional Nursing, Scholarly Inquiry for Nursing Practice: An International Journal, Encyclopedia of Nursing Research, Health Care for Women International, Nursing Leadership Forum, and the American Journal of Public Health. Dr. Strickland also initiated the development of the Nursing Citation Index. In addition to her many other professional activities, she has been a member of the Advisory Committee to The Director of the National Institutes of Health, National Center for Nursing Research National Advisory Council, Chairperson of the Board of Directors of the American Journal of Nursing Company, a member of the U.S. Congressional Black Caucus Health Brain Trust, and served as an intern to former U.S. Congressman Ralphe Metcalfe (D-Ill.).

 

Dr. Strickland has been recognized for her outstanding contributions to nursing through her election to the American Academy of Nursing, the youngest person ever elected into the Academy. A former columnist for the Baltimore Sun, her column titled "Nurse's Station," which appeared regularly in the health magazine section of the Morning and Evening Sun, won two health journalism awards in 1988. Six volumes of Measurement of Nursing Outcomes series , for which she identified the need and co-edited, won eight “American Journal of Nursing Book of the Year” Awards. Dr. Strickland has been selected as a Kellogg National Fellow, a fellowship program in leadership for the nation's top young professionals. She was also an Endowment for the Humanities Fellow in Bioethics and an American Nurses' Association Minority Doctoral Fellow, and selected as a Ford Foundation Fellow.

 

An internationally known specialist in nursing research, measurement, evaluation, maternal and child health and parenting, Dr. Strickland is frequently called upon as a consultant nationally and internationally, and has presented more than 200 lectures, speeches and workshops. Her research on expectant fathers has been featured in over 80 newspapers (including the Washington Post and the Chicago Tribune) and on over l,200 radio stations internationally. An Associated Press story about her NIH funded study of premenstrual syndrome (PMS) appeared in numerous newspapers across the nation, and has been featured on three television news programs. Dr. Strickland was one of the Emory site principal investigators for the Women's Health Initiative (WHI), one of the largest known clinical trial of its kind which studied 168,000 postmenopausal women nationally over the course of 9 years. She has appeared on national television shows including on NBC's "Frank Field's Health Field Show," "Straight Talk," ABC's “Nightly News with Peter Jennings” and on several local television programs. In addition to contributing to professional journals, she has written or contributed to 21 books.

Steven M. Teutsch became the Chief Science Officer, Los Angeles County Public Health in February 2009. He will continue his work on evidence-based public health and policy. He had been in Outcomes Research and Management program at Merck since October 1997 where he was responsible for scientific leadership in developing evidence-based clinical management programs, conducting outcomes research studies, and improving outcomes measurement to enhance quality of care. Prior to joining Merck he was Director of the Division of Prevention Research and Analytic Methods (DPRAM) at CDC where he was responsible for assessing the effectiveness, safety, and the cost-effectiveness of disease and injury prevention strategies. DPRAM developed comparable methodology for studies of the effectiveness and economic impact of prevention programs, provided training in these methods, developed CDC’s capacity for conducting necessary studies, and provided technical assistance for conducting economic and decision analysis. The Division also evaluated the impact of interventions in urban areas, developed the Guide to Community Preventive Services, and provided support for CDC’s analytic methods. He has served as a member of that Task Force and the U.S. Preventive Services Task Force which develops the Guide to Clinical Preventive Services as well as on Americas Health Information Community Personalized Health Care Workgroup. He currently chairs the Secretary's Advisory Committee on Genetics Health and Society, and serves on the Evaluation of Genomic Applications in Prevention and Practice (EGAPP) Workgroup as well as IOM panels.

 

Dr. Teutsch came to CDC in 1977, where he was assigned to the Parasitic Diseases Division and worked extensively on toxoplasmosis. He was then assigned to the Kidney Donor and subsequently the Kidney Disease Program. He developed the framework for CDC's diabetes control program. He joined the Epidemiology Program Office and became the Director of the Division of Surveillance and Epidemiology where he was responsible for CDC's disease monitoring activities. He became Chief of the Prevention Effectiveness Activity in 1992.

 

Dr. Teutsch was born in Salt Lake City, Utah. He received his undergraduate degree in biochemical sciences at Harvard University in 1970, an M.P.H. in epidemiology from the University of North Carolina School of Public Health in 1973, and his M.D. from Duke University School of Medicine in 1974. He completed his residency training in internal medicine at Pennsylvania State University, Hershey. He was certified by the American Board of Internal Medicine in 1977, the American Board of Preventive Medicine in 1995, and is a Fellow of the American College of Physicians and American College of Preventive Medicine. Dr. Teutsch is an Adjunct Professor at the Emory University School of Public Health, Department of Health Policy and Management and U. No. Carolina School of Public Health.

Dr. Teutsch has published over 150 articles and 6 books in a broad range of fields in epidemiology, including parasitic diseases, diabetes, technology assessment, health services research, and surveillance.

 

He resides in Los Angeles with his wife Carol Teutsch, M.D.

Dr. Veenstra is an Associate Professor in the Pharmaceutical Outcomes Research and Policy Program in the Department of Pharmacy, and a member of the Institute for Public Health Genetics at the University of Washington.  He graduated from the University of California San Francisco, with doctoral degrees in clinical pharmacy and computational chemistry, and conducted his postdoctoral training in outcomes research with the University of Washington.

 

Dr. Veenstra’s primary research interests are the clinical, economic, and policy implications of pharmacogenomic-based drug therapies.  His major research projects include cost-effectiveness evaluations of genetic tests for warfarin, breast cancer, and lung cancer therapies, and the development of quantitative frameworks for evaluating the clinical benefit-risk tradeoffs of genetic tests. 

 

Dr. Veenstra has significant experience developing disease simulation models for chronic diseases such as hepatitis B.  He has worked extensively with the Academy of Managed Care Pharmacy to develop guidelines and train decision makers in the practical application of cost-effectiveness models, and is an author of over 80 peer-reviewed publications and book chapters.

 

 

Home | About EGAPP | Understanding EGAPP | Working Group | Meetings | Topics | Methods | Evidence Reports | Recommendations | Contact Us
© 2009 Evaluation of Genomic Applications in Practice and Prevention (EGAPP)